Supreme Court Showdown: Bayer’s Roundup Cancer Lawsuits Under Scrutiny

The U.S. Supreme Court will review thousands of lawsuits against Bayer AG over claims that its Roundup weedkiller causes cancer. Bayer argues federal law preempts such claims and that the EPA has approved its product labels. This case could end years of litigation against Bayer, impacting its agriculture business.

The U.S. Supreme Court is poised to potentially shut down thousands of lawsuits targeting Bayer AG, with allegations that the active ingredient in its Roundup weedkiller causes cancer. The case will scrutinize the federal law's influence over state claims, as Bayer contends federal legislation should take precedence.

The hearings center around a Missouri court decision that awarded $1.25 million to plaintiff John Durnell, who claims his non-Hodgkin lymphoma resulted from prolonged exposure to glyphosate in Roundup. Bayer, backed by agricultural industry groups and the Trump administration, maintains that EPA findings negate any cancer warnings on its labels.

With over 100,000 legal claims linked to Roundup, a Supreme Court win for Bayer could conclude extended legal battles, affecting both the company's finances and its product's agricultural availability. A recent poll revealed significant public opposition to shielding companies from litigation over allegedly cancer-causing products, further highlighting the case's high stakes.